Pan-Ras-In-1 triggers cell wall lysis to eradicate Staphylococcus aureus
Abstract
Given the global crisis of antimicrobial resistance, the dual anticancer and antibacterial properties of certain agents have attracted increasing attention as a potential alternative to conventional antimicrobial approaches. In this study, we characterized the bactericidal activity of an anticancer molecule (Pan-Ras-In-1) against Staphylococcus aureus, a pathogen associated with refractory infection. In vitro assays revealed that Pan-Ras-In-1 has a more pronounced bactericidal effect on S. aureus cells than the traditional antibiotics vancomycin and levofloxacin. Furthermore, Pan-Ras-In-1 displayed potential therapeutic efficacy in vivo, as assessed using the murine systemic infection and skin abscess models, suggesting its potential for subsequent clinical applications. Exposure of S. aureus to Pan-Ras-In-1 activates CidA-associated peptidoglycan hydrolase systems, which partially mediate bacterial programmed cell death. Peptide-centric local stability analyses revealed that Pan-Ras-In-1 binds to TarA protein, suppressing wall teichoic acid polymer production. The combined action of two mechanisms enables Pan-Ras-In-1 to compromise bacterial cell wall integrity.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.